An experimental Alzheimer’s drug called lecanemab has been hailed as an historic breakthrough. But what does it actually mean for people living with the disease?
Listen to The Slow Newscast here: https://pod.fo/e/14fe19
Tortoise is a news start-up devoted to slow journalism. We take our time to tell stories that really matter. If you want more slow and considered journalism, you can become a member of Tortoise to get access to more of our stories, contribute to our journalism and join exclusive events.
Just go to tortoisemedia.com/friend and use the code Claudia50 to get a year's digital membership for £50.
Hosted on Acast. See acast.com/privacy for more information.
